Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike glycoprotein. Produced in genetically modified human embryonic kidney (HEK) 293 cells. This product contains genetically modified organisms (GMOs). The other excipients are L-histidine, L-histidine hydrochloride monohydrate, magnesium cholride hexahydrate, polysorbate 80, ethanol, sucrose, sodium chloride, disodium edeetate dihydrate, water for injections.

What COVID-19 AstraZeneca Gene Therapy looks like and contents of the pack

Solution for injection. The solution is colourless to slightly brown, clear to slightly opaque and particle free.

Pack sizes (not all pack sizes may be marketed):

o 10 dose vial (5 ml) in packs of 10 vials.

o 8 dose vial (4 ml) in packs of 10 vials.

Manufacturer

Medimmune UK Ltd

6 Renaissance Way

Liverpool L24 9JW

United Kingdom